Diabetes Clinical Trials

Showing 7461-7480 of 7,874 trials

Single Dose Study of PF-04991532 in Healthy Subjects

NCT01102673

The purpose of this study is to characterize the safety, tolerability, pharmacokinetics (PK) and preliminary food effect of PF-04991532 following single escalating oral doses in healthy adult subjects.

Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders

Pfizer18 participantsStarted Apr 2010

New Haven, Connecticut, United States

COMPLETEDPhase 3

Carbohydrate Counting in Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion

NCT01173991

The investigators postulate that carbohydrate (CHO) counting in adult patients with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) may improve glycemic control, glycemic variability and quality of life.

Diabetes Mellitus, Type 1Insulin Pump, Programmable

IRCCS San Raffaele61 participantsStarted Oct 2008

Milan, Italy

COMPLETEDPhase 2/3

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

NCT00499148

The purpose of the study was to evaluate the effect of an herbal extract on postprandial glycemia following a meal.

Type 2 Diabetes

Abbott Nutrition59 participantsStarted Aug 2006

Edina, Minnesota, United States • Cincinnati, Ohio, United States

COMPLETEDPhase 1

Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.

NCT01089205

Objective: To study Bioequivalence of Metformin Hydrochloride Extended Release 750 mg Tablets (Test formulation, Torrent Pharmaceuticals Ltd., India) Versus Glucophage XR® 750 mg Tablet (Reference formulation, Bristol-Myers Squibb company, USA) in Healthy volunteers under Fed Conditions. Study Design: An Open-Label, Randomized, 2-Period, 2-Treatment, Crossover, Single-Dose Bioequivalence Study

Type 2 Diabetes

Torrent Pharmaceuticals Limited

Single Dose Study of PF-04991532 in Healthy Subjects

Carbohydrate Counting in Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.

Related Searches

A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus

Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Observational Trial

Study of Cellular Impairments Involved in Diabetic Complications

Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Improving Aspirin Use in Diabetes: A Cluster Randomized Trial

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes

Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus

Personality of Diabetic Patients Will Influence Their Medical compliance-a 5 Years Cohort Follow up With Type D Personality